Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?

被引：1
|
作者：
Samson, M. [1 ,2 ,3 ]
Bonnotte, B. [1 ,2 ,3 ]
机构：
[1] CHU Dijon Bourgogne, Serv Med Interne, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[2] CHU Dijon Bourgogne, Immunol Clin, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[3] Univ Bourgogne Franche Comte, FHU Increase, Inserm U1098, F-21000 Dijon, France
来源：
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 02期
关键词：
Giant cell arteritis; Treatment; Tocilizumab; LARGE-VESSEL VASCULITIS; TAKAYASU ARTERITIS; DOUBLE-BLIND; THERAPY; TRIAL; ABATACEPT;
D O I：
10.1016/j.revmed.2017.11.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [41] Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
    Martin-Gutierrez, Adrian
    Loricera, Javier
    Narvaez, Javier
    Aldasoro, Vicente
    Maiz, Olga
    Vela, Paloma
    Romero-Yuste, Susana
    de Miguel, Eugenio
    Galindez-Agirregoikoa, Eva
    Fernandez-Lopez, Jesus C.
    Ferraz-Amaro, Ivan
    Sanchez-Martin, Julio
    Moya, Patricia
    Campos, Cristina
    Lopez-Gutierrez, Fernando
    Castaneda, Santos
    Blanco, Ricardo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 78 - 86
  • [42] TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS
    Calderon-Goercke, Monica
    Loricera, J.
    Prieto-Pena, D.
    Aldasoro, Vicente
    Castaneda, Santos
    Villa-Blanco, Ignacio
    Humbria, Alicia
    Moriano, Clara
    Romero-Yuste, Susana
    Narvaez, J.
    Gomez-Arango, Catalina
    Perez-Pampin, Eva
    Melero, Rafael
    Becerra-Fernandez, Elena
    Revenga, Marcelino
    Alvarez-Rivas, Noelia
    Galisteo, Carles
    Sivera, Francisca
    Olive, Alejandro
    Alvarez del Buergo, Maria
    Marena Rojas, Luisa
    Fernandez-Lopez, Carlos
    Navarro, Francisco
    Raya, Enrique
    Galindez, Eva
    Arca, Beatriz
    Solans-Laque, Roser
    Conesa, Arantxa
    Hidalgo, Cristina
    Vazquez, Carlos
    Andres Roman-Ivorra, Jose
    Lluch, Pau
    Manrique Arija, Sara
    Vela-Casasempere, Paloma
    de Miguel, Eugenio
    Torres-Martin, Carmen
    Carlos Nieto, Juan
    Ordas-Calvo, Carmen
    Salgado-Perez, Eva
    Luna-Gomez, Cristina
    Toyos Saenz de Miera, J. Francisco.
    Fernandez-Llanio, Nagore
    Garcia, Antonio
    Larena, Carmen
    Palmou-Fontana, Natalia
    Calvo-Rio, Vanesa
    Gonzalez-Vela, Carmen
    Corrales, Alfonso
    Varela-Garcia, Maria
    Aurrecoechea, Elena
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 818 - 819
  • [43] Utility of Tocilizumab in Visual Affection of Patients with Giant Cell Arteritis
    Calderon Goercke, Monica
    Loricera, Javier
    Prieto Pena, Diana
    Moriano Morales, Clara
    Diez Alvarez, Elvira
    Javier Narvaez, Francisco
    Mera, Antonio
    Perez Pampin, Eva
    Aldasoro, Vicente
    Varela-Garcia, Maria
    Alvarez-Rivas, Noelia
    Barbazan, Ceferino
    Ordas-Calvo, Carmen
    Sivera, Francisca
    Luna Gomez, Cristina
    Saenz de Miera, Francisco J. Toyos
    Conesa, Arantxa
    Navarro, Francisco
    Atienza-Mateo, Belen
    Luis Martin-Varillas, Jose
    Galindez-Agirregoikoa, Eva
    Calvo-Rio, Vanesa
    Cionzalez-Vela, Carmen
    Palmou-Fontana, Natalia
    Luis Hernandez, Jose
    Angel Gonzalez-Gay, Miguel
    Blanco, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Amsler, Jennifer
    Kysela, Iveta
    Tappeiner, Christoph
    Seitz, Luca
    Christ, Lisa
    Scholz, Godehard
    Stalder, Odile
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [45] Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy
    Higashida-Konishi, Misako
    Akiyama, Mitsuhiro
    Shimada, Tatsuya
    Hama, Satoshi
    Oshige, Tatsuhiro
    Izumi, Keisuke
    Oshima, Hisaji
    Okano, Yutaka
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (03) : 545 - 549
  • [46] TREATMENT OF GIANT CELL ARTERITIS WITH TOCILIZUMAB IN CLINICAL PRACTICE IN SWEDEN
    Di Giuseppe, D.
    Knight, A.
    Mohammad, A. J.
    Turesson, C.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 375 - 376
  • [47] Tocilizumab for relapsing and remitting giant cell arteritis: a case series
    Saha, Pratyasha
    Srikantharajah, Denesh
    Kaul, Arvind
    Sofat, Nidhi
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [48] Effectiveness of Dose Spacing with Tocilizumab in Giant Cell Arteritis Treatment
    Cowley, Sharon
    Kirby, Colm
    Harkins, Patricia
    Conway, Richard
    Murphy, Grainne
    Kane, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4784 - 4785
  • [49] Risks and benefits of tocilizumab monotherapy in giant cell arteritis Comment
    Cid, Maria C.
    Espigol-Frigole, Georgina
    LANCET RHEUMATOLOGY, 2021, 3 (09): : E606 - +
  • [50] REAL LIFE EXPERIENCE OF TOCILIZUMAB TREATMENT FOR GIANT CELL ARTERITIS
    Hutton, Lisa M. M.
    RHEUMATOLOGY, 2023, 62
12345